Press enter to search
Close search

Generics

Press enter to search
Close search
Open Menu

Generics

News and information on generic drugs sold in retail pharmacies, as well as their suppliers.

A man holding an FDA approved sign.

FDA approves Pfizer's Humira biosimilar, offers update on progress biosimilar approvals

Pfizer plans to launch Humira biosimilar in 2023.

A pharmacy stock room.

Study: USP quality standards support U.S. generics market

Public quality standards set forth by USP increased competition in the generic medicines market and reduced overall prescription drug costs by $11 billion in 2015 and 2016.

Fresenius Kabi introduces generic Emend

Fresenius Kabi's generic Emend provides clinicians with a treatment alternative that has a 24-month shelf life.

A man holding an FDA approved sign.

Breckenridge gets FDA green light for generic Tarceva

Tarceva and its generics had a market value of approximately $145 million during the year ended Sept, 30, 2019.

Teva taps Eli Kalif as executive vice president, CFO

Eli Kalif will join Teva as executive vice president and chief financial officer on Dec. 22.

An illustration of an envelope with a paper that has a check mark.

Glenmark gets FDA nod for generic Epiduo

Epiduo gel had a market value of about $33.7 million for the 12 month period ended September 2019, according to IQVIA.        

Teva, Celltrion launch their Rituxan biosimilar Truxima

Teva and Celltrion's Truxima is the first biosimilar to Genentech’s Rituxan (rituximab).  

Fresenius Kabi launches small-volume prefilled heparin sodium syringes

Fresenius Kabi is expanding its heparin and Simplist prefilled syringe portfolio with the addition of a small-volume presentation of Heparin.

A man holding an FDA approved sign.

Sandoz gets FDA green light for Neulasta biosimilar Ziextenzo

With the FDA approval of Ziextenzo — a biosimilar of Neulasta — Sandoz is the first and only company to offer long- and short-acting filgrastim biosimilar treatment options.

Camber gets FDA nod for generic Bentyl

Generic Bentyl is Camber's first injectable product to hit the market.

A boardroom with empty chairs.

Endo implements CEO succession plan

Paul Campanelli has been named Endo chairman of the board, and will continue as president and CEO until a successor is appointed.

The words approved in caps and red letters.

FDA approves third indication for Lupin’s generic Levoxyl

Lupin's levothyroxine sodium tablets now is approved as a generic of Synthroid, Unithroid, and Levoxyl.

The FDA headquarters.

SunGen gets FDA nod for lidocaine ointment

Lidocaine has a market value of about $60 million.

Aurobindo’s generic Lodosyn gets FDA OK

Carbidopa tablets had a market value of roughly $7.7 million for the 12 months ending August 2019, according to IQVIA.

Show More